24 weeks ago on Monday, August 21, 2017, I took my first injection of Tremfya (guselkumab) to treat my severe psoriasis. That day I witnessed a solar eclipse as I drove to the dermatology clinic in Sacramento. I recalled the day in grade school (February 26, 1979) when the last total solar eclipse occurred in the Northern Hemisphere. That's around the time when the first psoriasis lesions emerged on my skin. Almost forty years later, would Tremfya finally be the treatment to eclipse the nagging psoriasis all over my skin? A pattern has emerged.
I wrote this article for the National Psoriasis Foundation as an update to my Treat to Target experience earlier this year. The editor decided to take excerpts from below as a postscript and republish as An ongoing experiment with Treat to Target. See the postscript for a brief week 13 with Tremfya update.
Five years ago I wrote about the challenges of waiting for a new treatment, Stelara, to work after taking it for three weeks. It never did, even after six months. I find myself at a similar juncture today--a few weeks into Tremfya treatment wondering the same.
One week ago, I started taking Tremfya (guselkumab) for my psoriasis. The journey to taking that injection started months ago when I talked to my dermatologist about it. Here's how it's going so far.